OBERD Cofounder, Otho R. Plummer, Ph.D., Receives Roger A. Mann Award for Outstanding Clinical Paper at AOFAS

COLUMBIA, Mo., Oct. 22, 2020 /PRNewswire/ — OBERD, the leading global patient intelligence software company for optimizing patient outcomes and practice performance, today announced that its cofounder, Otho R. Plummer, Ph.D., together with  Joseph T. O’Neil, M.D. and Steven M. Raikin, M.D. received the 2020 Roger A. Mann Award for their paper titled, “Application of Computerized Adaptive Testing to the Foot and Ankle Ability Measure.” The award is given annually in recognition of the most outstanding clinical paper presented at the AOFAS (American Orthopaedic Foot & Ankle Society) Annual Meeting.

“One of the greatest inhibiting factors to research is outcomes data completed by the patient,” said Steven Raikin, M.D., Chief of Foot and Ankle Service at the Rothman Institute and Professor of Orthopaedic Surgery at the Sidney Kimmel Medical College of Thomas Jefferson University. “The opportunity to significantly decrease the number of questions that a patient needs to answer and thereby increase compliance and completion rates drew remarkable interest from the scientific community in the audience.” 

“It is incredibly gratifying to meaningfully impact this issue, and to have our efforts recognized in such a distinguished way,” said Dr. O’Neil, Foot and Ankle Surgeon at the Rothman Institute and Assistant Professor of Orthopaedic Surgery in the Sidney Kimmel Medical College, who presented the paper in a plenary session. “Receiving the highest award in the Orthopaedic Foot and Ankle world was only made possible by the collaboration between computer scientists at OBERD and clinical departments at the Rothman Orthopaedic Institute,” Raikin added.

“It’s been an honor to be able to partner with Drs. O’Neil and Raikin – two surgeons dedicated to excellence in research and practice,” said Otho Plummer, Ph.D., Chief Scientist at OBERD, Professor Emeritus of Computer Science at the University of Missouri. “The Rothman Institute has  long employed OBERD for data collection, and this result illustrates its value.”

The Roger A. Mann award has been given annually since 1994 for the Outstanding Clinical Paper presented in the scientific program of the AOFAS Annual Meeting. It is named in honor of the distinguished surgeon, educator, and researcher Roger A. Mann, M.D. Dr. Mann has also served the community as president of the AOFAS and as author of the widely used textbook Mann’s Surgery of the Foot and Ankle, (9th Edition).

The full clinical paper entitled, ‘”Application of Computerized Adaptive Testing to the Foot and Ankle Ability Measure,” will appear in a forthcoming issue of Foot & Ankle International.

About OBERD

OBERD is the leading global patient intelligence software company for optimizing patient outcomes and practice performance. The company’s software analytics platform seamlessly captures and measures patient-reported outcomes (PROs) across every touchpoint of a patient’s experience to provide smart insights that can be used to transform how practices care for their patients and manage their business operations.

For more information, visit www.OBERD.com. Follow OBERD on Twitter at @oberdnews and LinkedIn at https://www.linkedin.com/company/oberd.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/oberd-cofounder-otho-r-plummer-phd-receives-roger-a-mann-award-for-outstanding-clinical-paper-at-aofas-301158447.html

SOURCE OBERD

Staff

Recent Posts

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

3 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

4 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

18 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

21 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

21 hours ago